维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="LR Hanson"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The blood velocity profile in the ductus venosus inlet expressed by the mean/maximum velocity ratio显示文摘	Kiserud T Hellevik LR Hanson MA	1998	Ultrasound Med Biol1998，24，9：	1
2	Intranasal delivery to the centralnervous system: mechanisms and experimental considerations显示文摘	Dhuria SV Hanson LR Frey WH	2010	JPharm Sci2010，99，4：	1
3	Intranasal delivery to the central nervous system:mechanisms and experimental considerations显示文摘	Dhuria SV Hanson LR Frey WH	2010	Pharm Sci2010，99，3：	1
4	Trigeminal pathways deliver alow molecular weight drug from the nose to the brain and orofacialstructures显示文摘	Johnson NJ Hanson LR Frey WH	2010	Mol Pharm2010，7，3：	1
5	Intranasal delivery to the central nervous system: mechanisms and experimental considerations显示文摘	Dhuria SV Hanson LR Frey n W	2010	J Pharm Sci2010，99，4：	1
6	The blood velocity profile in the ductus venosus inlet expressed by the mean/maximum velocity ratio 显示文摘	Kiserud T Hellevik LR Hanson MA	1998	Ultrasound Med Biol1998，24，：	1
7	Intranasal delivery of neurotrophie factors BDNF, CNTF, EPO, and NT-4 to the CNS显示文摘	Alcald-Barraza SR Lee MS Hanson LR	2010	J Drug Target2010，18，3：	1
8	Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS显示文摘	Alcala- Barraza SR Lee MS Hanson LR	2010	J Drug Ttarget2010，18，3：	1
9	In/ranasal drug target- ing of hypocretin-l(orexin-A) to the central nervous system 显示文摘	SV Dhuria LR Hanson WH Frey II	2009	J Pharm Sci2009，98，6：	1
10	Intranasal delivery tothe central nervous system ; mechanisms and experimentalconsiderations显示文摘	Dhuria SV Hanson LR Frey WH 2nd	2010	J Pharm Sci2010，99，4：	1
11	Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT - 4 to the CNS 显示文摘	Alcal6 - Barraza SR Lee MS Hanson LR	2010	J Drug Target2010，18，3：	1
12	Protective effects of in- tranasal losartan in the APP/PS1 transgenic mouse model of Alzhei- mer disease显示文摘	Danielyan L Klein R Hanson LR	2010	Rejuvenation Res2010，13，：	1
13	Intranasal deferoxamine provides increased brain exposure and significant protection in rat schemic stroke 显示文摘	Hanson LR Roeytenberg A Martinez PM	2009	J Phar- macol Exp Ther2009，330，3：	1
14	Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease显示文摘	Hanson LR Frey WH	2008	BMC Neurosci2008，9，3：	1
15	The window of opportunity for treatment of focal cerebral ischemia with noninvasive intranasal insulin-like growth factor-1 in rat显示文摘	Liu XF Fawcett JR Hanson LR	2004	Journal of Stroke & Cerebrovascular Diseases2004，13，1：	1
16	Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke 显示文摘	Hanson LR Roeytenberg A Martinez PM	2009	J Pharmacol Exp Ther2009，330，：	1
17	Intranasal delivery of deferoxamine reduces spatial memory loss in APP/PS1 mice 显示文摘	Hanson LR Fine JM Renner DB	2012	Drug Deliv Transl Res2012，2，：	1
18	Delivery of interferon-b to the monkey\snervous system following intranasal administration显示文摘	Thorne RG Hanson LR	2008	Neuroscience2008，152，：	1
19	Novel vasoconstrictor formulation\sto enhance intranasal targeting of neuropeptide therapeutics to the\scentral nervous system显示文摘	Dhuria SV Hanson LR Frey W H	2009	J Pharm Exp Ther2009，328，：	1
20	Intranasal delivery to the central nervous system : Mechanisms and ex- perimental considerations 显示文摘	Dhuria SV Hanson LR Frey WH 2nd	2010	J Pharm Sci2010，99，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示